CytomX Therapeutics (CTMX) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for CytomX Therapeutics (CTMX) over the last 11 years, with Q3 2025 value amounting to 0.68.
- CytomX Therapeutics' Asset Utilization Ratio fell 1970.98% to 0.68 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68, marking a year-over-year decrease of 1970.98%. This contributed to the annual value of 0.86 for FY2024, which is 9586.29% up from last year.
- Per CytomX Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.68 for Q3 2025, which was down 1970.98% from 1.03 recorded in Q2 2025.
- CytomX Therapeutics' 5-year Asset Utilization Ratio high stood at 1.35 for Q1 2025, and its period low was 0.07 during Q1 2021.
- In the last 5 years, CytomX Therapeutics' Asset Utilization Ratio had a median value of 0.36 in 2023 and averaged 0.47.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 4657.69% in 2021, then skyrocketed by 14247.62% in 2023.
- Quarter analysis of 5 years shows CytomX Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then soared by 107.75% to 0.22 in 2022, then surged by 119.38% to 0.48 in 2023, then soared by 122.38% to 1.06 in 2024, then crashed by 35.94% to 0.68 in 2025.
- Its Asset Utilization Ratio stands at 0.68 for Q3 2025, versus 1.03 for Q2 2025 and 1.35 for Q1 2025.